Edaravone

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2004 publications

Edaravone attenuates acrylamide-induced nephrotoxicity by modulating the endoplasmic reticulum stress pathway in rats.

Edaravone attenuates acrylamide-induced nephrotoxicity by modulating the endoplasmic reticulum stress pathway in rats.

Journal: Free radical research
Published: June 08, 2026

Targeting lipid nanoparticle mediated co-delivery of edaravone and kaempferol for amyotrophic lateral sclerosis therapy.

Targeting lipid nanoparticle mediated co-delivery of edaravone and kaempferol for amyotrophic lateral sclerosis therapy.

Journal: Nanoscale
Published: May 22, 2026

Amyotrophic Lateral Sclerosis: A Review.

Amyotrophic Lateral Sclerosis: A Review.

Journal: JAMA
Published: May 11, 2026

Bridging the Funding Gap in Drug Development for Amyotrophic Lateral Sclerosis.

Bridging the Funding Gap in Drug Development for Amyotrophic Lateral Sclerosis.

Journal: Neurology. Clinical practice
Published: May 11, 2026

Protective Effects of 3,4-Dihydropyrimidin-2(1H)-one Derivatives on Oxidative Stress Injury following Subarachnoid Hemorrhage.

Protective Effects of 3,4-Dihydropyrimidin-2(1H)-one Derivatives on Oxidative Stress Injury following Subarachnoid Hemorrhage.

Journal: ACS chemical neuroscience
Published: April 28, 2026

Nephroprotective role of edaravone against polystyrene nanoplastic-induced endoplasmic reticulum stress in Wistar rats.

Nephroprotective role of edaravone against polystyrene nanoplastic-induced endoplasmic reticulum stress in Wistar rats.

Journal: Toxicology mechanisms and methods
Published: April 27, 2026

Reply to letter to the editor: "The temporal mismatch between MRI-based prognostic classification and the therapeutic window".

Reply to letter to the editor: "The temporal mismatch between MRI-based prognostic classification and the therapeutic window".

Journal: Journal of the neurological sciences
Published: April 26, 2026

Amyotrophic lateral sclerosis (ALS): current perspectives and the Swiss ALS Registry

Amyotrophic lateral sclerosis (ALS): current perspectives and the Swiss ALS Registry

Journal: Praxis
Published: April 23, 2026

Retraction: Observations on the efficacy of edaravone dexborneol in preventing post-stroke depression and its inflammatory mechanism: a prospective, randomized, control trial.

Retraction: Observations on the efficacy of edaravone dexborneol in preventing post-stroke depression and its inflammatory mechanism: a prospective, randomized, control trial.

Journal: Frontiers in neuroscience
Published: April 20, 2026

Crude Astragalus polysaccharides ameliorate cognitive impairment by preserving blood-brain barrier integrity and suppressing GSDMD-mediated pyroptosis in jellyfish-envenomed mice.

Crude Astragalus polysaccharides ameliorate cognitive impairment by preserving blood-brain barrier integrity and suppressing GSDMD-mediated pyroptosis in jellyfish-envenomed mice.

Journal: Frontiers in pharmacology
Published: April 11, 2026

Effect of edaravone on synaptic damage in Alzheimer's disease via Rho/ROCK signaling.

Effect of edaravone on synaptic damage in Alzheimer's disease via Rho/ROCK signaling.

Journal: Pakistan journal of pharmaceutical sciences
Published: April 04, 2026

Strophioglanes A-E and (±)-Trigoxyphin K, ent-Cleistanthane Diterpenoids from Strophioblachia glandulosa var. cordifolia.

Strophioglanes A-E and (±)-Trigoxyphin K, ent-Cleistanthane Diterpenoids from Strophioblachia glandulosa var. cordifolia.

Journal: Journal of natural products
Published: March 27, 2026
Showing 1-12 of 2,004

Last Updated: 06/30/2026